Abstract:Sensory hypersensitivities are common and distressing features of Fragile X Syndrome (FXS). While there are many drug interventions that reduce behavioral deficits in Fmr1 mice and efforts to translate these preclinical breakthroughs into clinical trials for FXS, evidence-based clinical interventions are almost non-existent potentially due to lack of valid neural biomarkers. Local circuit function in sensory networks is dependent on the dynamic balance of activity in inhibitory/excitatory synapses. Studies are needed to examine the association of electrophysiological alterations in neural systems with sensory and other clinical features of FXS to establish their clinical relevance. Adolescents and adults with FXS (n = 38, Mean age = 25.5, std = 10.1; 13 females) and age matched typically developing controls (n = 40, Mean age = 27.7, std = 12.1; 17 females) completed auditory chirp and auditory habituation tasks while undergoing dense array electroencephalography (EEG). Amplitude, latency, and percent change (habituation) in N1 and P2 event-related potential (ERP) components were characterized for the habituation task; time-frequency calculations using Morlet wavelets characterized phase-locking and single trial power for the habituation and chirp tasks. FXS patients showed increased amplitude but some evidence for reduced habituation of the N1 ERP, and reduced phase-locking in the low and high gamma frequency range and increased low gamma power to the chirp stimulus. FXS showed increased theta power in both tasks. While the habituation finding was weaker than previously found, the remaining findings replicate our previous work in a new sample of patients with FXS. Females showed less deficit in the chirp task but not the habituation task. Abnormal increases in gamma power were related to more severe behavioral and psychiatric features as well as reductions in neurocognitive abilities. Replicating electrophysiological deficits in a new group of patients using different EEG equipment at a new data collection site with differing levels of environmental noise that were robust to data processing techniques utilizing multiple researchers, indicates a potential for scalability to multi-site clinical trials. Given the robust replicability, relevance to clinical measures, and preclinical evidence for sensitivity of these EEG measures to pharmacological intervention, the observed abnormalities may provide novel translational markers of target engagement and potentially outcome measures in large-scale studies evaluating new treatments targeting neural hyperexcitability in FXS.

Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography—What Can be Interpreted from the Available Information?

Specific EEG resting state biomarkers in FXS and ASD

Autism Symptoms in Fragile X Syndrome

Developmental associations between motor and communication outcomes in Fragile X syndrome: Variation in the context of co-occurring autism

Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation

Autism Symptoms in Children and Young Adults With Fragile X Syndrome, Angelman Syndrome, Tuberous Sclerosis Complex, and Neurofibromatosis Type 1: A Cross-Syndrome Comparison

Similar Gap-Overlap Profiles in Children with Fragile X Syndrome and IQ-Matched Autism

Differential cognitive and behavioral development from 6 to 24 months in autism and fragile X syndrome

Disentangling autism spectrum and attention-deficit/hyperactivity symptoms over development in fragile X syndrome

Fragile X and autism: Intertwined at the molecular level leading to targeted treatments

Neural correlates of face processing among preschoolers with fragile X syndrome, autism spectrum disorder, autism siblings, and typical development

Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome

A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome

Autism spectrum disorder and epileptic encephalopathy: common causes, many questions

Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance.

Developmental studies in fragile X syndrome

Reliability of Resting-State Electrophysiology in Fragile X Syndrome

Sex Differences in Resting EEG Power in Fragile X Syndrome.

Differentiating Social Preference and Social Anxiety Phenotypes in Fragile X Syndrome Using an Eye Gaze Analysis: a Pilot Study

21. Auditory EEG Phenotypes in Single Gene Disorders: Insight into Heterogeneity in Idiopathic Autism

Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome